HealthEconomics.Com - The Resource for Health Outcomes Professionals

search   
Sign Up For Our Newsletter
Email:  


industry news

Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007–2008

Employers Push Costs for Health on Workers By REED ABELSON

Final Part D Agreement Between CMS and Drugmakers Provides More Time to Pay Health Plans

From NCE to NICE: the role of Pharmacoeconomics

What Is the Price Benchmark to Replace Average Wholesale Price (AWP)?

NICE announces development of further Quality Standards

Avastin patient access scheme too complicated, says NICE

Comparative Effectiveness—of What? Evaluating Strategies to Improve Population Health

Market access and patient access schemes

Market access: Risk sharing and alternative pricing schemes

US breast cancer drug decision 'marks start of death panels'

Medical Affairs at the centre of life sciences innovation

Rising Burden of Diseases Drives the Pharmaceutical Industry in East Africa Says Frost & Sullivan

Is Health Care Special?

CRD international register of ongoing systematic reviews

Hospitals Should Plan Now for Value-Based Purchasing, Which May Be a Game-Changer

Comparative Effectiveness Research

Health care and revenue competition in Britain

Literature Review Examines Value of Managed Care Pharmacy Tools

Compelling Evidence Regarding Effectiveness Of Managed Care Pharmacy Tools In Achieving Intended Outcomes

IBM, Aetna roll out cloud-based clinical decision support system

Health Economics Spending Increases 45% in Emerging Markets, 8% in the US

Health Secretary Andrew Lansley announces new NHS ‘quality standards’

PharmaNet, Abacus ally on ‘real world' research

The Impact of Employer Health and Productivity Management Practices

NICE ‘yes’ in 80% of treatment appraisals

Providers Have Won Majority of RAC Claims Denials They Have Appealed

Study examines UK’s NICE as model producer of HTA

Health Secretary Andrew Lansley announces new NHS ‘quality standards’

Government kicks off consultation on outcomes framework

Will More Insurers Control Health Care Costs Better?

Will Janssen-Cilag's ADHD YouTube Video Go Viral and Win an Award?

Reimbursement by Distributors

Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region.Yang BM, Lee K. Value Health. 2009 Nov-Dec;12 Suppl 3:S1-2.

Value-based Pricing to be Introduced to the UK Pharma Industry by 2014

Disclosing Industry Relationships — Toward an Improved Federal Research Policy

Pharmacoeconomics: friend or foe?

NHS reform – a bold vision or a dangerous gamble?

GSK's Coverup of Avandia's Heart Risk Data: Is This How the Entire Industry Views Its Repsonsibility to Patients?

Oncology drug price cuts announced in Italy related to perfomance based schemes

US And European Prices Aren’t So Different After All

Grand challenges in pharmacoeconomics and health outcomes

White Paper: An Economic Assessment of the Relationship between Price Regulation and Incentives to Innovate in the Pharmaceutical Industry

Clarifying Sources of Geographic Differences in Medicare Spending

Is The Impact of Comparative Effectiveness Reports Being Evaluated? by Rebecca Singer Cohen Rebecca Singer Cohen View Author Bio and Bryan Luce

Biosimilars’ Price Dynamic in Europe, Dr Matthias Liefner of Simon Kucher and Partners.

AQoL Website - Centre for Health Economics, Monash University

“How To Negotiate Salary”, a submitted article by Bill Cebak - Founder / Headhunter Global HEOR, Market Access and Medical Communications Practice since 1993

AMCP eDossier System: A Partnership that Works! AMCP News June 2010

Dartmouth Atlas: A Response to Its Researchers

D2 Review : APHA and AMCP introduce MTM Connections a fantastic site for new professional opportunities

Including Pregnant Women in Clinical Research Called ‘Imperative’

Selecting Quality and Resource Use Measures A Decision Guide for Community Quality Collaboratives

Spending More on Drugs Doesn’t Mean Spending Less On Other Care

Trendspotter: Consumer Survey Shows Opposition to Evidence-Based Medicine

Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Former CMS Official’s Off-Label Work May Help Reform Law’s CER Center

Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data

Integrated Health Ecosystem Key to Creating Better Health Outcomes and Managing Costs for Employers and Health Plans

The Health Care Economy: New Questions About Costs, Quality And Care

The Amazing Maze of US Health Care

Universal Healthcare Myths | New Health Care Bill Facts

Pricing, profits and pharmacoeconomics - for whose benefit?

Symposium on Research Methods for Clinical and Comparative Effectiveness Studies – Part II

Funny Pharmacy Videos. These are Hysterical! Particularly "The PharmG's - Boom Intervention" Rap


HEOR Analysts and Consultants - Europe and US
Company Name: IMS Health
Position Type Full-time
Location:
Date Posted: Dec 18, 2009
Experience:
Job Details
Essentially every major pharmaceutical and biotechnology company in the world relies on IMS. With more than 50 years of experience in providing market intelligence, we offer clients information, analytics and consulting capabilities that are simply unmatched. With our longstanding tradition of product development, tailored to meet emerging client needs and innovations recognized industry-wide, we’ve earned our reputation as the “gold standard.”

With direct access to the world’s most comprehensive information, analytic and consulting/research resources, IMS experts in Health Economics and Outcomes Research (HEOR) deliver deep insights into product safety, efficacy, cost, value for money and affordability. We are one of only a few organizations that integrate health economics, outcomes research, pricing and market access and have senior staff involved in each project. Our work spans the spectrum of therapeutic and pathology areas, providing challenge and variety for our people.

Due to continued success and expansion of our offerings in response to client demand, we are expanding our global HEOR team throughout Europe, the US and Asia. We are proud to offer an invigorating atmosphere and challenging, varied projects that enable our people to realize their full potential. Our diverse mix of clients from Pharmaceutical, Medical Device, Diagnostic and Biotech companies, as well as our interactions with regulatory organizations, provides exposure to solving the health economics and outcomes research issues facing healthcare companies and authorities around the world. As a result our people really do help to demonstrate the value of medicine.

Do you have what it takes to join our world-class team?

HEOR Analysts and Consultants
Europe & US

As a result of the continued success of our business we have opportunities for ambitious, motivated individuals to join our team in various countries throughout Europe and the US. We seek both experienced HEOR Consultants who have first project management and client management experience; and Analysts who seek the exciting, stimulating development opportunities IMS offers.

Analysts and Consultants are regularly involved in outcomes research, economic analysis of the possible impact of health care interventions and the natural history of a disease. With a diverse mix of clients, typically including the global top 20 pharmaceutical and biotech companies, our work spans the full spectrum of therapeutic and disease areas, providing challenge and variety for our people. Assignments typically require problem solving, outcomes research and economic analysis, communication and dissemination of our findings and the delivery of high quality, timely solutions to meet our client needs.
Working in teams with experienced HEOR researchers, our consultants and analysts undertake research programmes and evaluations of the impact of health care interventions and the burden of a disease.

For the Analyst positions we will consider both people with first consulting, industry and management experience in this field and also those who have just finished their Master’s degree and wish to develop their expertise in health economics consulting. The degree of management, project and technical responsibility offered will depend on the experience and ability of the individual.

For the Consultant positions the candidate will be expected to manage projects and to assume responsibility for client liaison, leading small teams and delivery to deadline. We would expect some experience in the pharmaceutical industry, in a consulting environment or at a similar level of responsibility in another organisation.

All applicants should have:

• A good first degree and/or postgraduate qualification in economics, health services research, health economics, epidemiology or a related, relevant discipline
• An understanding of economics, health economics and outcomes research
• Good interpersonal and communication skills
• Ability to undertake the critical appraisal of evidence
• Good organisational skills and the ability to balance multiple projects
• Fluent spoken and excellent written English

We are particularly interested to receive applications from people who can demonstrate:
• An understanding of, or experience with, the pharmaceutical or related industries
• Good understanding of and interest in the international health care environment
• Project management experience
• Numerical and quantitative skills, such as experience of epidemiological, financial, business or economic modelling
• Systematic review and meta analysis training and experience

The ability to deliver high quality work within timelines is essential, as is a flexible and team-oriented approach. As a significant number of our clients are based overseas, projects involve occasional international travel.

In return, you can expect the rich variety of projects – both globally and locally – that comes from working for a world-class organization such as IMS, along with the chance to work with leaders in the field of HEOR, and the support, commitment and career development framework to challenge and enhance your career on both a local and global stage – as well as the Total Reward package you would expect of working for one of the world’s leading consultancies.

Want to know more?

Visit: www.imshealth.com/pma/heor and www.imshealth.com/pma/heor/recruitment


Please mark your application “HEOR Analyst or Consultant” and send it with your CV and a covering letter to HEORapplications@uk.imshealth.com. If you have any questions please call Liz Coventry, our Talent Acquisition Manager, on +44 203 075 5162.


 
 
 


 

Insurance Resources: Even healthy people need life insurance.
Get life insurance quotes today.

 

sponsored by






































Become a sponsor



How are we doing? Take our survey





Copyright © 2007, HealthEconomics.Com